ASIA NEWS: Don Agro International sees an 8.9 million tonnes increase in crops harvested. This is due to land bank acquisitions, and the implementation of innovative technologies
| | | | | | | | | | | | | | | | | | | | |

ASIA NEWS: Don Agro International sees an 8.9 million tonnes increase in crops harvested. This is due to land bank acquisitions, and the implementation of innovative technologies

SINGAPORE, Nov 24, 2021 – (ACN Newswire) – Don Agro International Limited (the “Company” or “Don Agro”) and its subsidiaries (collectively the “Group”), one of the largest agricultural companies based in the Rostov region of Russia is pleased to announce that it has achieved a 8.9 thousand tonne growth in total crops harvested, with 72.3…

ASIA NEWS: Inaugural Asia Summit on Global Health opens today
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

ASIA NEWS: Inaugural Asia Summit on Global Health opens today

HONG KONG, Nov 24, 2021 – (ACN Newswire) – Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (ASGH) opened today at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format, offering both online…

BUSINESS: Seelos Therapeutics Announces The Acquisition Of An Exclusive License To IX Biopharma’s Proprietary Wafer Based Delivery Platform For Sublingual Ketamine
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Seelos Therapeutics Announces The Acquisition Of An Exclusive License To IX Biopharma’s Proprietary Wafer Based Delivery Platform For Sublingual Ketamine

NEW YORK, Nov. 24, 2021 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced it has entered into an exclusive license agreement (License Agreement), whereby it acquired a worldwide license (excluding China, Taiwan, Macau and Hong Kong) from…

BUSINESS: $494 Million Silver Iodide Markets – Global Opportunity Analysis And Industry Forecast, 2021-2030 – ResearchAndMarkets.com
| | | | | | | | | | | | | | | |

BUSINESS: $494 Million Silver Iodide Markets – Global Opportunity Analysis And Industry Forecast, 2021-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Silver Iodide Market by Application: Global Opportunity Analysis and Industry Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering. The silver iodide market was valued at $257.6 million in 2020, and is projected to reach $494.0 million by 2030, growing at a CAGR of 6.8% from 2021 to 2030. Silver iodide is a…

BUSINESS: 2021 Industrial Valves And Actuators Growth Opportunities Report – ResearchAndMarkets.com
| | | | | | | | | | | | | | | |

BUSINESS: 2021 Industrial Valves And Actuators Growth Opportunities Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Industrial Valves and Actuators Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This study is an analysis of the global industrial valves and actuators market. It also details the growth potential of this market in the short, medium, and long terms. There is also an in-depth coverage of the growth of…

BUSINESS: Global Silver Iodide Markets Report 2020-2030 – Market Driven By The Increase In Cloud Seeding Demand From Numerous Countries, U.S. & UAE
| | | | | | | | | | | | | | | | |

BUSINESS: Global Silver Iodide Markets Report 2020-2030 – Market Driven By The Increase In Cloud Seeding Demand From Numerous Countries, U.S. & UAE

Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) — The “Silver Iodide Market by Application: Global Opportunity Analysis and Industry Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering. The silver iodide market was valued at $257.6 million in 2020, and is projected to reach $494.0 million by 2030, growing at a CAGR of 6.8% from 2021…

FRONT PAGES: Treatment For Glioblastoma May Be Possible By Targeting Tumor Blood Vessel Growth
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

FRONT PAGES: Treatment For Glioblastoma May Be Possible By Targeting Tumor Blood Vessel Growth

A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma. TMEM230 increases tissue vascularization by 3 mechanisms: inducing tumor cell migration and intussusceptive remodeling of existing blood vessels;…

BUSINESS: GLMIM Parts Expands Its Product Line With A Stainless Steel Gearbox
| | | | | | | | | | | | | | | | |

BUSINESS: GLMIM Parts Expands Its Product Line With A Stainless Steel Gearbox

San Diego, CA, November 23, 2021 –(PR.com)– The new launch of parts by the GLMIM brand was much anticipated by the top international industrial sectors after they experienced working with them. Greelife MIM Parts Co., Ltd. have successfully rendered their patrons with highly efficient Precision Metal Parts that boost the accuracy of the products. Moreover, their…

CRYPTO CURRENCY NEWS: Why Crypto Needs To Be Regulated
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

CRYPTO CURRENCY NEWS: Why Crypto Needs To Be Regulated

CRYPTO CURRENCY NEWS: Source: Adobe/ninefotostudioViktor Prokopenya is a London-based fintech investor and the Founder of VP Capital, an investment vehicle focused on the technology sector. ______ Could we live in a world without rules? The theory is that we could live without government. Our ancestors did it. This is known as anarchy, which can be…

BUSINESS: CStone Pharmaceuticals Y Jiangsu Hengrui Pharmaceuticals Anuncian Una Alianza Estrategica Y Un Acuerdo De Licencia Exclusivo Para Anticuerpos Monoclonales Anti-CTLA-4 CS1002 En La Gran China
| | | | | | | | | | | | | |

BUSINESS: CStone Pharmaceuticals Y Jiangsu Hengrui Pharmaceuticals Anuncian Una Alianza Estrategica Y Un Acuerdo De Licencia Exclusivo Para Anticuerpos Monoclonales Anti-CTLA-4 CS1002 En La Gran China

– CStone otorgó los derechos exclusivos a Hengrui para la investigación, el desarrollo, el registro, la fabricación y la comercialización de anticuerpos monoclonales anti-CTLA-4 CS1002 en la región de la Gran China – CStone conservará los derechos para desarrollar y comercializar anticuerpos monoclonales anti-CTLA-4 CS1002 fuera de la Gran China – CStone y Hengrui se asociarán…

BUSINESS: Aesthetic Medicine Market Report Up To 2031 Visiongain Research Inc
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Aesthetic Medicine Market Report Up To 2031 Visiongain Research Inc

Visiongain has published a new report on Aesthetic Medicine Market Report to 2031: Forecasts By Product (Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck, and others) Non-invasive Procedures (Botox injections, Soft tissue fillers, Chemical peel, Laser hair removal, Microdermabrasion, and Others) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/aesthetic-medicine-market/#download_sampe_div COVID-19…

BUSINESS: Biofrontera Inc. Will Report Third Quarter Financial Results November 30, 2021
| | | | | | |

BUSINESS: Biofrontera Inc. Will Report Third Quarter Financial Results November 30, 2021

WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial results for the three and nine months ended September 30, 2021 before the opening of the U.S. financial markets on Tuesday, November 30, 2021 and will hold a conference call…

GAMING: PS5 Lead System Architect Mark Cerny Says We’re In “Third Era” Of Gaming History
| | | | | | | | | | |

GAMING: PS5 Lead System Architect Mark Cerny Says We’re In “Third Era” Of Gaming History

In a video from Wired released on Friday, Mark Cerny, the Lead System Architect behind the PS5 hardware, breaks down the process of creating the incredibly popular (and powerful) console. Cerny touts the widespread adoption of ray tracing as just as significant a shift as the move from 2D pixelated graphics to 3D polygonal graphics…

BUSINESS: Astrazeneca Is The First Organization To Receive Best Place To Work For Women Accreditation In Egypt
| | | | | | | | | | | | | | | |

BUSINESS: Astrazeneca Is The First Organization To Receive Best Place To Work For Women Accreditation In Egypt

CAIRO, Nov. 23, 2021 /PRNewswire/ — AstraZeneca Egypt, an affiliate of the multinational pharmaceutical and biopharmaceutical company, was recently certified as a Best Place to Work for women marking it the first organization in Egypt to receive the accreditation. The certification is based on an HR analysis of the company policies focusing on women and…

RECALL: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall Of Levetiracetam Injection, USP Due To Lack Of Sterility Assurance
| | | | | | | | | | |

RECALL: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall Of Levetiracetam Injection, USP Due To Lack Of Sterility Assurance

Summary Company Announcement Date: November 19, 2021 FDA Publish Date: November 22, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Lack of sterility assurance Company Name: Sagent Pharmaceuticals, Inc. Brand Name: Product Description: Company Announcement CHICAGO, IL – November 19, 2021 – Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four…

FRONT PAGES: A Wearable Device Can Detect Opioid Overdose And Reverse It
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

FRONT PAGES: A Wearable Device Can Detect Opioid Overdose And Reverse It

Newswise — A research team at the University of Washington has developed a wearable device to detect and reverse an opioid overdose. The device, worn on the stomach like an insulin pump, senses when a person stops breathing and moving, and injects naloxone, a lifesaving antidote that can restore respiration. The results demonstrate the proof-of-concept of…

FRONT PAGE: Promising Treatment For Alexander Disease Moves From Rat Model To Human Clinical Trials
| | | | | | | | | | | | | | | | | | | | | | | | | | |

FRONT PAGE: Promising Treatment For Alexander Disease Moves From Rat Model To Human Clinical Trials

Newswise — MADISON, Wis. — Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition.It’s a significant step in efforts…

BUSINESS: Priority Dumpster Rental Utica Reports – Marketing Alliance with Real Estate Consortium
| | | | | | | | | | | | | | | | | | |

BUSINESS: Priority Dumpster Rental Utica Reports – Marketing Alliance with Real Estate Consortium

The business will team up with the investor group in order to improve their area-wide outreach and marketing efforts Priority actually created a new local marketing collaboration with National Real Estate Network, a national association of investors, professionals and designers – working towards the empowerment and training of a new class of genuine estate specialists.…

HEALTH: FDA Generic Drug Program Shows Progress Toward Lowering Costs
| | | | | | | | | | | |

HEALTH: FDA Generic Drug Program Shows Progress Toward Lowering Costs

Nov. 18, 2021 — At least one generic drug approval – and ideally more than one – is needed to spur competition and reduce the overall cost to consumers taking a particular medication. This is especially true if a drug is not easy to produce or can only be used to treat a limited number…

BUSINESS: Obseva Announces U.S. FDA Acceptance Of New Drug Application For Linzagolix
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Obseva Announces U.S. FDA Acceptance Of New Drug Application For Linzagolix

FDA Accepts NDA for Linzagolix for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland November 22, 2021 – Obseva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today…

End of content

End of content